CLINICAL_TRIALS
trial_result
· 2025-05-08
Clinical Trial Update: Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts [Phase 2]
Summary
Phase 2 trial evaluating the safety and efficacy of the VDMN-21 Patch in subjects with verruca vulgaris (common warts) has completed, reporting safety and effic…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Veradermics, Inc. | Conditions: Verruca Vulgaris, Warts | Phase 2 | Status: COMPLETED